The human osteoblast hFOB1.19 (catalog: CRL-11372), human osteosarcoma cell lines U2OS (catalog: HTB-96), and MG63 (catalog: CRL-1427) were sourced from the American Type Culture Collection (Manassas, VA, USA). U2OS and MG63 were cultured in Dulbecco’s modified Eagle medium (catalog: BE12-604F, Lonza, Basel, Switzerland) supplemented with 10% fetal bovine serum (catalog: F7524, Sigma-Aldrich, St. Louis, MO, USA). hFOB1.19 cells were cultivated in hFOB1.19 complete medium (catalog: EP-ML-0353, Elabscience, Wuhan, China). All cells were kept at 37 °C in a 5% CO2 environment.
Parental U2OS and MG63 cells were initially exposed to 3 ng/mL (0.01 µM) MTX [15]. Subjecting the parental cell lines to stepwise raised MTX concentrations, MTX-resistant subclones were produced.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.